1-5 of 5
Gail Morris
Close
Sort by
Journal Articles

Randomized Phase II Study of Combined Epigenetic Therapy: Decitabine Vs. Decitabine and Valproic Acid in MDS and AML

Jean-Pierre Issa, Ryan Castoro, Farhad Ravandi-Kashani, Stefan Faderl, Xuelin Huang, Elihu Estey, Gautam Borthakur, Gail Morris, Guillermo Garcia-Manero, Hagop M Kantarjian
Journal: Blood
Blood (2008) 112 (11): 228.
https://doi.org/10.1182/blood.V112.11.228.228
Published: 2008
Journal Articles

Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes

Clinical Trials & Observations
Guillermo Garcia-Manero, Hui Yang, Carlos Bueso-Ramos, Alessandra Ferrajoli, Jorge Cortes, William G. Wierda, Stefan Faderl, Charles Koller, Gail Morris, Gary Rosner, Andrey Loboda, Valeria R. Fantin, Sophia S. Randolph, James S. Hardwick, John F. Reilly, Cong Chen, Justin L. Ricker, J. Paul Secrist, Victoria M. Richon, Stanley R. Frankel, Hagop M. Kantarjian
Journal: Blood
Blood (2008) 111 (3): 1060–1066.
https://doi.org/10.1182/blood-2007-06-098061
Published: 2008
Includes: Supplemental data
Journal Articles

Phase I Study of Suberoylanilide Hydroxamic Acid (SAHA) and Decitabine in Patients with Relapsed, Refractory or Poor Prognosis Leukemia.

Farhad Ravandi, MD, Stefan Faderl, MD, Deborah Thomas, MD, Jan Burger, MD, Charles Koller, MD, Guillermo Garcia-Manero, MD, Gail Morris, RN, Ritva Torma, RN, Hagop Kantarjian, MD, Jean-Pierre Issa, MD
Journal: Blood
Blood (2007) 110 (11): 897.
https://doi.org/10.1182/blood.V110.11.897.897
Published: 2007
Journal Articles

Final Results of a Phase I Study of the Histone Deacetylase Inhibitor Vorinostat (Suberoyanilide Hydroxamic Acid, SAHA), in Patients with Leukemia and Myelodysplastic Syndrome.

Guillermo Garcia-Manero, MD, Hui Yang, MD, PhD, Blanca Sanchez-Gonzalez, MD, Srdan Verstovsek, MD, Alessandra Ferrajoli, MD, Michael Keating, MD, Michael Andreeff, MD, Susan O’Brien, MD, Jorge Cortes, MD, William Wierda, MD, PhD, Stefan Faderl, MD, Charles Koller, MD, Jan Davis, RN, Gail Morris, RN, Jean-Pierre Issa, MD, Stanley R. Frankel, MD, Victoria Richon, PhD, Bernard Fine, PhD, Hagop Kantarjian, MD
Journal: Blood
Blood (2005) 106 (11): 2801.
https://doi.org/10.1182/blood.V106.11.2801.2801
Published: 2005
Journal Articles

Hypomethylation Dynamics Following Decitabine Therapy in Chronic Myelogenous Leukemia.

Jean-Pierre J. Issa, M.D., Vazganush Gharibyan, Ph.D., Jaroslav Jelinek, M.D., Ph.D., Gail Morris, RN, Srdan Verstovsek, M.D., Moshe Talpaz, M.D., Guillermo Garcia-Manero, M.D., Hagop M. Kantarjian, M.D.
Journal: Blood
Blood (2004) 104 (11): 2956.
https://doi.org/10.1182/blood.V104.11.2956.2956
Published: 2004